EESE yields 2000.00% · JNJ yields 2.14%● Live data
📍 EESE pulled ahead of the other in Year 1
Combined, EESE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EESE + JNJ for your $10,000?
Energy and Environmental Services, Inc. manufactures and sells custom liquids and solid chemicals for the oil, gas, and agricultural industries. It provides oilfield chemicals for frac and stimulation, completion, and production phases, including scale inhibitors, corrosion inhibitors, packer fluid inhibitors, paraffin dispersant compounds H2S scavengers, biocides, water treating compounds, demulsifiers, emulsion breakers, nonemulsifiers, frac foamers, clay stabilizers, liquid KCL substitutes, cross linkers, wetting agents/surfactants, friction reducers, anti-sludge agents, mutual solvents, silt suspenders, iron sequestrants, iron control products, complete acid gel systems, xylene/acid emulsifiers, and HCl acid retarders under the Enduro-Tech name. The company also offers custom chemical blending, toll blending, and private labeling services to downhole production chemical companies. In addition, it provides powdered coatings under the Enduro-Bond trademark; and Ecozyme system technologies in the industries of agriculture, livestock feed supplements / products, and malodor elimination. Energy and Environmental Services, Inc. is based in Edmond, Oklahoma. As of November 4, 2015, Energy and Environmental Services, Inc. operates as a subsidiary of BlueHawk Energy, Inc.
Full EESE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.